It has also been demonstrated that miR-145 targets MUC1 in metastatic breast cancer [14], p70S6K1 in colon cancer [15], c-Myc in non-small cell lung cancer [16] and the transcription factor STAT1 in colon cancer [17]. Here, MUC1 is linked to malignant colon neoplasm.